Boston Scientific SVP acquires 2,930 shares via 401(k)

BOSTON SCIENTIFIC CORP executive Emily Woodworth, SVP, Global Controller and CAO, reported a discretionary acquisition of 2,930 shares of common stock on 2026-08-11 at $51.19 per share.

Rhea-AI Filing Summary

BOSTON SCIENTIFIC CORP executive Emily Woodworth, SVP, Global Controller and CAO, reported a discretionary acquisition of 2,930 shares of common stock on 2026-08-11 at $51.19 per share. The shares were acquired indirectly through a rebalance in the company’s 401(k) Retirement Savings Plan, bringing her indirect 401(k) holdings to 2,930 shares.

A separate holding entry shows 3,123 shares held directly, which includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based on the most current data available.

Insider Trade Summary

Discretionary: 2,930 shares

Discretionary 2 txns

Insider Woodworth Emily

Role SVP, Global Controller and CAO

Type	Security	Shares	Price	Value
Discretionary	Common Stock F1	2,930	$51.19	$150K
holding	Common Stock F2	--	--	--

Holdings After Transaction: Common Stock — 2,930 shares (Indirect, By 401(k)); Common Stock — 3,123 shares (Direct)

Footnotes (2)

1. F1. Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.
2. F2. Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.

Key Figures

Shares acquired: 2,930 shares Acquisition price: $51.19 per share Indirect holdings after transaction: 2,930 shares +2 more

5 metrics

Shares acquired 2,930 shares Discretionary 401(k) rebalance on 2026-08-11

Acquisition price $51.19 per share Non-derivative common stock transaction

Indirect holdings after transaction 2,930 shares Held indirectly By 401(k) after acquisition

Direct holdings reported 3,123 shares Directly held common stock including ESPP shares

Buy transactions 0 No open-market buy coded as P; one acquire under A/I discretionary

Key Terms

Rule 16b-3(f), 401(k) Retirement Savings Plan, Employee Stock Purchase Plan, indirect holdings

4 terms

Rule 16b-3(f) regulatory

"Discretionary transaction under Rule 16b-3(f)"

401(k) Retirement Savings Plan financial

"rebalance their holdings under the Company's 401(k) Retirement Savings Plan"

Employee Stock Purchase Plan financial

"Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

indirect holdings financial

"indirect 401(k) holdings to 2,930 shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Boston Scientific (BSX) executive Emily Woodworth report in this Form 4?

Emily Woodworth reported a discretionary acquisition of 2,930 BSX shares of common stock at $51.19 per share through the company’s 401(k) Retirement Savings Plan, plus an updated direct holding figure.

How many Boston Scientific (BSX) shares did Emily Woodworth acquire and how?

She acquired 2,930 shares of BSX common stock via a rebalance election in the company’s 401(k) Retirement Savings Plan, recorded as a discretionary transaction under Rule 16b-3(f) on 2026-08-11.

What are Emily Woodworth’s indirect BSX holdings after the reported transaction?

Following the 401(k) rebalance, Emily Woodworth’s indirect holdings in BSX common stock held "By 401(k)" total 2,930 shares, reflecting the discretionary acquisition reported in this Form 4.

What are Emily Woodworth’s direct Boston Scientific (BSX) share holdings?

The Form 4 shows 3,123 BSX shares held directly by Emily Woodworth. This figure includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based on the most current data available.

Was the Boston Scientific (BSX) transaction made under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not marked, and the transaction is described instead as a discretionary transaction under Rule 16b-3(f) tied to a 401(k) rebalance election.

At what price were the acquired Boston Scientific (BSX) shares recorded?

The 2,930 BSX shares acquired through the 401(k) rebalance were recorded at a price of $51.19 per share, as specified in the non-derivative transaction details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 04:09 PM Accepted by SEC EDGAR 08/12/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Woodworth Emily

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MASSACHUSETTS 01752-1234

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Global Controller and CAO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		I(1)		2,930	A	$51.19	2,930	I	By 401(k)
Common Stock								3,123(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.

2. Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.

	/s/ Susan Thompson, Attorney-in-Fact	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)